Status:
COMPLETED
PERL Continuous Glucose Monitoring (CGM) Study
Lead Sponsor:
Joslin Diabetes Center
Collaborating Sponsors:
The Leona M. and Harry B. Helmsley Charitable Trust
University of Minnesota
Conditions:
Diabetic Nephropathies
Eligibility:
All Genders
18-70 years
Brief Summary
Seven-point capillary profiles have shown that mean glucose correlates with both diabetic retinopathy and nephropathy risk. However, there remains great controversy as to whether the degree of variabi...
Detailed Description
Participants who consent to the study will have an Abbott Freestyle Libre Pro sensor placed on the back of their upper arm at their first PERL visit after this ancillary study has begun and at all sub...
Eligibility Criteria
Inclusion
- • Being an active participant in the PERL clinical trial
Exclusion
- Having completed PERL Visit 16
- Pregnancy
- History of skin reactions in relation to the application of Abbott Freestyle Libre Pro
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT03334318
Start Date
October 1 2017
End Date
December 31 2021
Last Update
March 29 2022
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Barbara Davis Center / University of Colorado Denver
Aurora, Colorado, United States, 80045
2
Emory University - Grady Memorial Hospital
Atlanta, Georgia, United States, 30303
3
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611
4
Joslin Diabetes Center
Boston, Massachusetts, United States, 02215